Our position is that FDA has a job, which is to do the science on these kinds of issues and then tell the public what theyve learned from the science, he said
However, recent clinical evidence suggests prescription-based approachesincluding compounded GLP-1 medicationsmay address underlying metabolic factors that diet programs alone cannot target
Delayed effects on subsequent night sleep included shorter sleep onset, reduced stage 1 percentage, and improved sleep efficiency
These broad estimates indicate the potential number of non-elderly adults who meet the clinical criteria for GLP-1 drugs, although employers and insurers may have more restrictive eligibility standards for coverage
Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities
But I also wish we had the ability to address for socioeconomic confounders in papers like this